Floatz logo

Belinostat

Systemic Anaplastic Large Cell Lymphoma

Corvus Pharmaceuticals, Inc.Small moleculePhase 3Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

15 Active assets in the Systemic Anaplastic Large Cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Mingzhi Zhang
Phase 4BB
Crizotinib
Mingzhi Zhang
Phase 4BB
Inno-206
Huiqiang Huang
Phase 2BB
DEXAMETHASONE
Huiqiang Huang
Phase 2BB
Cyclophosphamide
Huiqiang Huang
Phase 2BB

View all 33 →

Same molecule, other indications

Belinostat is also rated in:

HIV InfectionsDormant
BB
Indicative ·
67 / 100
View asset →
ovarian carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
diffuse large B-cell lymphomaDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →